Panasonic Fulfills 100 Thousand Solar Lanterns Project in Its 100th Anniversary, Bringing Light to Off-grid Communities Globally
Panasonic Corporation announced the successful completion of its 100 Thousand Solar Lanterns Project, which has brought light to off-grid communities in 30 countries through 131 non-profit and other organizations in the last five years. Since the project's inception in February 2013, a total of 102,716 solar lanterns have been donated, including 5,004 lanterns given today to Indonesia, which has marked the end of the project.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180208005520/en/
Ikat tapestries, which are sold as handicraft goods, can be woven at night, to increase the income for the Riangbaring Village in Indonesia. (Photo: Business Wire)
The project was part of Panasonic's Corporate Social Responsibility (CSR) initiatives that make use of its technologies and products in line with the company's management philosophy since its founding in 1918, that is, to make a contribution to the progress and development of society and the well-being of people through its business activities.
There are estimated 1.1 billion people who live without electricity in emerging and developing countries. Panasonic's project got started with the aim to help solve social issues stemming from a lack of light in the fields of medicine, education and economy, among others. Panasonic has strived towards the goal of donating a total of 100,000 units of solar lanterns by 2018, its centenary year.
Panasonic's lanterns, which were brought to communities in cooperation with non-profit, non-governmental and other international organizations, helped alleviate problems and brought about improvements in such areas as education, health and medicine, and women's independence. The solar lanterns have also contributed to the Sustainable Development Goals (SDGs) set by the United Nations to mobilize global efforts to end poverty, protect the planet and ensure prosperity.
With the completion of the 100 Thousand Solar Lanterns Project, Panasonic now carries on its efforts to deliver more light to people in regions without access to electricity in a new framework. In Japan, Panasonic employees took part in the project through its employee benefit program. In addition to this, to expand the activity beyond the company, Panasonic will begin utilizing crowdfunding this April to enable anyone who shares the spirit of this campaign to participate by pledging a small amount of money.
Ms. Rika Fukuda, General Manager, CSR & Citizenship Group of Panasonic, which led the project, said: "We are very pleased to achieve the 100,000 goal. As a global corporate citizen, we remain committed to helping people living without electricity solve problems, with the aim to build an inclusive society where everyone enjoys life by sharing the joy with each other." The company will also continue contributing to SDGs through activities that utilize its business, she added.
Summary of activities
Major Outcomes of the Project Contributing to the UN’s SDGs
1. “Affordable and clean energy”
- Reduced use of kerosene lamps by 37.7% (Myanmar)
2. “Good health and well-being”
- 2,434 children born in rooms well-lit by lanterns (Myanmar)
3. “Quality education”
- 100% pass rate in school tests for progressing to next academic level (Myanmar)
4. “Gender equality”
- Approximately 40% increase in income due to increased opportunities for women such as working at night (India)
5. “No poverty”
- Fuel costs for kerosene lamps are reduced by 50% per month (Cambodia)
Sustainable Development Goals
Sustainable Development Goals are a set of goals adopted by countries at a special United Nations summit in September 2015 for the period from 2016 to 2030. The SDGs comprise of 17 goals and 169 targets aimed at realizing sustainability, and it is the UN's intention that no one should be left behind. The SDGs are universal, and require the combined effort from all nations, developing and advanced.
100 THOUSAND SOLAR LANTERNS PROJECT
About the BG-BL03 solar lanterns donated to Indonesia
100 THOUSAND SOLAR LANTERNS PROJECT Facebook page
Panasonic's Sustainability Initiatives
Panasonic Donates 1,200 Solar Lanterns to Central Vietnam (Oct 16, 2017)
Panasonic Donates 3,060 Solar Lanterns to Humanitarian &
Non-Governmental Organizations in Myanmar Bringing Total Number of
Donations to 14,924 Throughout 5 Years (Sep 20, 2017)
Panasonic Donates Over 2,000 Solar Lanterns to Cambodian NPOs, Bringing
Total Number of Donations to 13,516 Throughout Five Years (Aug 30, 2017)
Global Communications Department
Global PR Office
Click here to go to Media Contact form
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Ultra-Low Power Lattice sensAI Leads Mass Market Enablement of Artificial Intelligence in Edge Devices21.5.2018 12:00 | Pressemelding
Lattice Semiconductor Corporation (NASDAQ: LSCC) today unveiled Lattice sensAI™ – a complete technology stack combining modular hardware kits, neural network IP cores, software tools, reference designs and custom design services – to accelerate integration of machine learning inferencing into broad market IoT applications. With solutions optimized for ultra-low power consumption (under 1 mW–1 W), small package size (5.5 mm2 –100 mm2), interface flexibility (MIPI® CSI-2, LVDS, GigE, etc.), and high-volume pricing (~$1-$10 USD), Lattice sensAI stack fast-tracks implementation of edge computing close to the source of data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005011/en/ (Graphic: Business Wire) “Lattice sensAI addresses the unmet need for flexible, low cost, ultra-low power AI silicon solutions suited for rapid deployment across a wide range of emerging, mass market IoT applications,” said Deepak Boppana, senior
NioCorp Awards Contract to Rockwell Automation on Groundbreaking Critical Minerals, Mining and Processing Facility in Nebraska21.5.2018 12:00 | Pressemelding
NioCorp Developments Ltd. (TSX: NB, OTCQX: NIOBF), a developer of superalloy metals, has awarded a major contract to Rockwell Automation (NYSE: ROK) to engineer, design and procure process automation and instrumentation for NioCorp’s proposed critical minerals, mining and processing facility in Elk Creek, Nebraska. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005228/en/ Three superalloy metals – niobium, scandium and titanium – are expected to be produced by the facility as early as 2021. These critical materials are used in the aerospace, defense, automotive, clean energy, commercial aviation and mega-infrastructure sectors. Generally, these superalloys enable increased strength and lighter weight in transportation and other systems, leading to better fuel efficiency and lower greenhouse gas and other air emissions, according to NioCorp. “We selected Rockwell Automation and its partners to automate our process equip
Biosimilars could facilitate early access to life changing biological treatments for patients says Celltrion Healthcare21.5.2018 11:27 | Pressemelding
At the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting in Baltimore, Celltrion Healthcare today advocated for healthcare systems to introduce biologics earlier in a patient’s treatment regimen in order to improve clinical outcomes. Several studies show that the early introduction of biologics can bring greater clinical benefit to patients.1,2,3,4,5,6 However, only a limited number of patients have access to biological treatment due to the high-cost of biologics and current reimbursement policies determined by pharmacoeconomic evaluations. Since the introduction of biosimilars, the overall cost of biological treatments has reduced in Europe, allowing an increased number of patients to access this important treatment option earlier in their course of treatment.7 Professor Jørgen Jahnsen said, “For the treatment of inflammatory bowel disease, biological treatments are proven to be the most efficacious medical therapy and their ea
Dole’s Joint Venture Recycling Company Celebrates 25 Years21.5.2018 11:00 | Pressemelding
Dole Food Company announced today that Recyplast S.A., an innovative plastic recycling company based in Costa Rica and with joint ownership including a subsidiary of Dole Fresh Fruit, recently surpassed 25 years in its mission to dramatically reduce and reuse agricultural waste. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005160/en/ Raul Martinez (right), General Manager of Dole Standard Fruit de Costa Rica, receives a plaque from Jose Miguel Ramirez, General Manager of Recyplast, in recognition of the contribution of Dole's banana plantations in the correct handling, storage, and provision of field plastic waste. The plastic recycling facility pioneered the collection of field plastics after use in banana growing operations in Costa Rica. This reuse and recycling process includes reclamation of plastic bags that protect bananas from weather and insects, as well as the collection of plastic twine used to prop the ba
ViiV Healthcare Receives EU Marketing Authorisation for Juluca (dolutegravir/rilpivirine), the First 2-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV21.5.2018 10:11 | Pressemelding
ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the European Commission has granted marketing authorisation for Juluca (dolutegravir 50mg/rilpivirine 25mg) for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor or integrase inhibitor.1 Juluca is a 2-drug regimen of dolutegravir (ViiV Healthcare), the most widely prescribed integrase inhibitor worldwide,2 and rilpivirine (Janssen Sciences Ireland UC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson).1 Deborah Waterhouse, CEO ViiV Healthcare said, “The European Commission Decision for Juluca is very positive news for people living with
Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-121.5.2018 10:06 | Pressemelding
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission has granted marketing authorisation for JULUCA® (dolutegravir 50mg [ViiV Healthcare]/rilpivirine 25mg [Janssen Sciences Ireland UC]).1 ViiV Healthcare, as the marketing authorisation holder, will market dolutegravir/rilpivirine in all countries in the European Union and European Economic Area. Dolutegravir/rilpivirine is the first two-drug regimen, once-daily, single-pill for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase inhibitor (INI).1 “The European Commission Decision for dolutegravir/rilpivirine marks a significant milestone in our 25-year commitment to make HIV history,” said Brian Woo